Mental Health Clinics in Ladysmith, WI Accepting Medicare
7 Mental Health Clinics found. Showing 1 - 7
 Rusk Co. Dept. Of Health & Human Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 311 Miner Ave E Ste C240, Ladysmith, WI 54848 Phone: 715-532-2299 Fax: 715-532-2126 |
Marriage & Family Health Service, Ltd Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 612 Worden Ave E, Ladysmith, WI 54848 Phone: 715-832-0238 Fax: 715-832-0771 |
Willow Tree Mental Health Clinic, Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 105 Lake Ave W, Ladysmith, WI 54848 Phone: 715-532-0281 Fax: 715-532-0399 |
Rusk Co. Dept. Health & Human Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 311 Miner Ave E Ste C240, Ladysmith, WI 54848 Phone: 715-532-2299 Fax: 715-532-2126 |
Community Support Center Of Rusk County Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 219 W 2nd Str N, Ladysmith, WI 54848 Phone: 715-532-5940 Fax: 715-532-5947 |
Rusk Co. Dept. Of Health & Human Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 311 Miner Ave E Ste C240, Ladysmith, WI 54848 Phone: 715-532-2299 Fax: 715-532-2126 |
Rusk Co. Dept. Of Health & Human Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 311 Miner Ave E Ste C240, Ladysmith, WI 54848 Phone: 715-532-2299 Fax: 715-532-2126 |
News Archive
RegeneRx joint venture retains Ora to carry out RGN-259/GBT201 clinical trials in U.S.
RegeneRx Biopharmaceuticals, Inc. today announced its U.S. joint venture with G-treeBNT (ReGenTree LLC) has retained Ora, Inc. to conduct a phase 3 clinical trial for the orphan disorder, neurotrophic keratopathy (NK), and a 2b/3 dose-response, confirmatory trial for dry eye syndrome (DES) in the U.S. Both trials will be testing ReGenTree's preservative-free eye drops, RGN-259/GBT201, this year.
CardiAQ Valve Technologies announces first human implant of transcatheter bioprosthetic mitral heart valve
CardiAQ Valve Technologies (CardiAQ), which has developed the world's first self-conforming and self-anchoring technology for nonsurgical transfemoral-transseptal percutaneous Transcatheter Mitral Valve Implantation (TMVI), today announced that its second-generation bioprosthetic mitral heart valve was successfully implanted as a compassionate treatment into a 72-year-old male suffering from severe mitral regurgitation (MR 4+) with multiple co-morbidities and ineligible for alternate treatment modalities.
TSU researchers develop new approach to diagnose adenocarcinoma
Scientists have developed a new approach to the diagnosis of adenocarcinoma - a malignant tumor of the prostate gland. Artificial intelligence is used to determine oncopathology and determine the stage of the disease with this approach.
Disabled children in developing countries are more likely to experience harsh punishment
Children with disabilities who live in developing countries are more likely to experience harsh punishment than children without disabilities in those countries. That's the conclusion of a new study that looked at data from nationally representative samples of about 46,000 parents and other caregivers of 2- to 9-year-olds in 17 low- and middle-income countries; most prior research on children with disabilities has been done in developed countries.
Capitol Hill briefing addresses neglected tropical diseases
At a Global Network for Neglected Tropical Diseases (NTD) briefing, held in conjunction with the Congressional Malaria and NTD Caucus in Washington, D.C. on Thursday, "U.S. researchers, pharmaceutical companies and government officials [said] they are making progress in an effort to curb [NTDs], but that they need more money and outside help," VOA News.
› Verified 8 days ago